Bond Gilead Medica 1.65% ( US375558BY84 ) in USD
| Issuer | Gilead Medica |
| Market price | |
| Country | United States
|
| ISIN code |
US375558BY84 ( in USD )
|
| Interest rate | 1.65% per year ( payment 2 times a year) |
| Maturity | 30/09/2030 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 1 000 USD |
| Total amount | 1 000 000 000 USD |
| Cusip | 375558BY8 |
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) |
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) |
| Next Coupon | 01/04/2026 ( In 50 days ) |
| Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. Gilead Sciences Inc. (US375558BY84, CUSIP 375558BY8) issued a USD 1,000,000,000 bond with a 1.65% coupon, maturing on September 30, 2030, currently trading at 84.01%, paying semi-annually, in minimum increments of 1000, and rated BBB+ by S&P and A3 by Moody's. |
Français
Italiano
United States